Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1979 May;63(5):912–921. doi: 10.1172/JCI109391

Deficient Serum Bactericidal Activity Against Escherichia Coli in Patients with Cirrhosis of the Liver

Joshua Fierer 1,2,3, Fred Finley 1,2,3
PMCID: PMC372032  PMID: 376551

Abstract

The serum bactericidal activity (SBA) of cirrhotic patients was compared with that of normal individuals using the release of 51Cr from radiolabeled Escherichia coli as the assay method. 80% (22/27) of patients were found to have deficient SBA against at least one of three smooth, serum-sensitive test strains of E. coli. Cirrhotic patients were found to have normal levels of serum lysozyme. Although some patients were mildly hypocomplementemic, this abnormality did not correlate with the presence of a bactericidal defect. Bactericidal antibody in normal and cirrhotics' sera was limited to the immunoglobulin (Ig)M class. Purified IgM from patients with deficient SBA against E. coli 0111 had lower concentrations of bactericidal antibody for that E. coli than did IgM from normal sera; the calculated bactericidal activity of total serum IgM was also lower. The bactericidal defect in cirrhotic serum could be completely corrected by either human antiserum to the homologous strain of E. coli or by purified, normal human IgM. However, because higher concentrations of IgM were required to restore normal SBA to a cirrhotic's serum than to agammaglobulinemic serum, there may be an inhibitor of bactericidal antibody in addition to a deficiency of bactericidal IgM antibody to E. coli in the serum of patients with cirrhosis. The bactericidal activity of the alternative complement pathway was also assessed. Sera from cirrhotic patients had no deficit in SBA attributable to the alternative complement pathway. In fact, in some, the activity of the alternative complement pathway was supernormal, compensating in part for the deficit in IgM-mediated SBA.

Full text

PDF
912

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjorneboe M., Prytz H., Orskov F. Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver. Lancet. 1972 Jan 8;1(7741):58–60. doi: 10.1016/s0140-6736(72)90060-8. [DOI] [PubMed] [Google Scholar]
  2. Bradfield J. W. Control of spillover. The importance of Kupffer-cell function in clinical medicine. Lancet. 1974 Oct 12;2(7885):883–886. doi: 10.1016/s0140-6736(74)91213-6. [DOI] [PubMed] [Google Scholar]
  3. Braude A. I., Douglas H., Davis C. E. Treatment and prevention of intravascular coagulation with antiserum to endotoxin. J Infect Dis. 1973 Jul;128(Suppl):157–164. doi: 10.1093/infdis/128.supplement_1.s157. [DOI] [PubMed] [Google Scholar]
  4. Britton S., Möller G. Regulation of antibody synthesis against Escherichia coli endotoxin. I. Suppressive effect of endogenously produced and passively transferred antibodies. J Immunol. 1968 Jun;100(6):1326–1334. [PubMed] [Google Scholar]
  5. CAROLI J., PLATTEBORSE R. Septicémie porto-cave; cirrhoses du foie et septicémie à colibacille. Sem Hop. 1958 Feb 18;34(8/2):472–87/SP. [PubMed] [Google Scholar]
  6. Conn H. O., Fessel J. M. Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine (Baltimore) 1971 May;50(3):161–197. doi: 10.1097/00005792-197105000-00002. [DOI] [PubMed] [Google Scholar]
  7. DULBECCO R., VOGT M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954 Feb;99(2):167–182. doi: 10.1084/jem.99.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DeMeo A. N., Andersen B. R. Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. N Engl J Med. 1972 Apr 6;286(14):735–740. doi: 10.1056/NEJM197204062861401. [DOI] [PubMed] [Google Scholar]
  9. Des Prez R. M., Bryan C. S., Hawiger J., Colley D. G. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid. Infect Immun. 1975 Jun;11(6):1235–1243. doi: 10.1128/iai.11.6.1235-1243.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Durack D. T., Beeson P. B. Protective role of complement in experimental Escherichia coli endocarditis. Infect Immun. 1977 Apr;16(1):213–217. doi: 10.1128/iai.16.1.213-217.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fierer J., Finley F., Braude A. I. A plaque assay on agar for detection of gram-negative bacilli sensitive to complement. J Immunol. 1972 Nov;109(5):1156–1158. [PubMed] [Google Scholar]
  12. Fierer J., Finley F., Braude A. I. Release of 51Cr-endotoxin from bacteria as an assay of serum bactericidal activity. J Immunol. 1974 Jun;112(6):2184–2192. [PubMed] [Google Scholar]
  13. George E. A., Shields J. B., Cabal E. C., Schulz R. C., Donati R. M. Hepatic kinetics of 99mtechnetium sulfur colloid in cirrhosis. J Nucl Med Allied Sci. 1977 Jul-Sep;21(3):107–112. [PubMed] [Google Scholar]
  14. Gerding D. N., Khan M. Y., Ewing J. W., Hall W. H. Pasteurella multocida peritonitis in hepatic cirrhosis with ascites. Gastroenterology. 1976 Mar;70(3):413–415. [PubMed] [Google Scholar]
  15. Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med. 1969 Jun 1;129(6):1307–1326. doi: 10.1084/jem.129.6.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Guckian J. C., Christensen W. D., Fine D. P. Trypan blue inhibits complement-mediated phagocytosis by human polymorphonuclear leukocytes. J Immunol. 1978 May;120(5):1580–1586. [PubMed] [Google Scholar]
  17. Hall W. H., Manion R. E., Zinneman H. H. Blocking serum lysis of Brucella abortus by hyperimmune rabbit immunoglubulin A. J Immunol. 1971 Jul;107(1):41–46. [PubMed] [Google Scholar]
  18. Hannon R., Haire M., Wisdom G. B., Neill D. W. The use of indirect immunofluorescence to evaluate the gel filtration method of fractionating human immunoglobulins. J Immunol Methods. 1975;8(1-2):29–36. doi: 10.1016/0022-1759(75)90078-2. [DOI] [PubMed] [Google Scholar]
  19. Jones E. A., Sherlock S., Crowley N. Bacteraemia in association with hepatocellular and hepatobiliary disease. Postgrad Med J. 1967 Mar;43(Suppl):7–11. [PubMed] [Google Scholar]
  20. KENT J. F., FIFE E. H., Jr Precise standardization of reagents for complement fixation. Am J Trop Med Hyg. 1963 Jan;12:103–116. doi: 10.4269/ajtmh.1963.12.103. [DOI] [PubMed] [Google Scholar]
  21. Langone J. J., Boyle M. D., Borsos T. Effect of concanavalin A on the functional activity of hemolytic antibody. Immunol Commun. 1977;6(3):283–296. doi: 10.3109/08820137709050798. [DOI] [PubMed] [Google Scholar]
  22. MUSCHEL L. H. Bactericidal activity of normal serum against bacterial cultures. II. Activity against Eschericha coli strains. Proc Soc Exp Biol Med. 1960 Mar;103:632–636. doi: 10.3181/00379727-103-25619. [DOI] [PubMed] [Google Scholar]
  23. Mackenzie M. R., Warner N. L., Linscott W. D., Fudenberg H. H. Differentiation of human IgM subclasses by the ability to interact with a factor resembling the first component of complement. J Immunol. 1969 Sep;103(3):607–612. [PubMed] [Google Scholar]
  24. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  25. Marney S. R., Jr, Des Prez R. M. Comparison of the effects of divalent ion chelating agents on complement-mediated hemolysis in rabbit and human serum. J Immunol. 1969 Nov;103(5):1044–1049. [PubMed] [Google Scholar]
  26. McCutchan J. A., Katzenstein D., Norquist D., Chikami G., Wunderlich A., Braude A. I. Role of blocking antibody in disseminated gonococcal infection. J Immunol. 1978 Nov;121(5):1884–1888. [PubMed] [Google Scholar]
  27. Reed W. P., Albright E. L. Serum factors responsible for killing of Shigella. Immunology. 1974 Jan;26(1):205–215. [PMC free article] [PubMed] [Google Scholar]
  28. Schulkind M. L., Kenny K., Herzberg M., Robbins J. B. The specific secondary biological activities of rabbit IgM and IgG anti-Salmonella typhimurium 'O' antibodies isolated during the development of the immune response. Immunology. 1972 Aug;23(2):159–170. [PMC free article] [PubMed] [Google Scholar]
  29. Spiegelberg H. L. Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol. 1974;19(0):259–294. doi: 10.1016/s0065-2776(08)60254-0. [DOI] [PubMed] [Google Scholar]
  30. TISDALE W. A. Spontaneous colon bacillus bacteremia in Laennec's cirrhosis. Gastroenterology. 1961 Jan;40:141–148. [PubMed] [Google Scholar]
  31. Targan S. R., Chow A. W., Guze L. B. Spontaneous peritonitis of cirrhosis due to Campylobacter fetus. Gastroenterology. 1976 Aug;71(2):311–313. [PubMed] [Google Scholar]
  32. Ziegler E. J., Douglas H., Braude A. I. Human antiserum for prevention of the local shwartzman reaction and death from bacterial lipopolysaccharides. J Clin Invest. 1973 Dec;52(12):3236–3238. doi: 10.1172/JCI107524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zucker S., Hanes D. J., Vogler W. R., Eanes R. Z. Plasma muramidase: a study of methods and clinical applications. J Lab Clin Med. 1970 Jan;75(1):83–92. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES